733 related articles for article (PubMed ID: 16914137)
1. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
2. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
Inagaki N; Shiraishi N; Igeta K; Nagao M; Kim JF; Chikumoto T; Itoh T; Katoh H; Tanaka H; Nagai H
Eur J Pharmacol; 2010 Jan; 626(2-3):283-9. PubMed ID: 19818345
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.
Takano N; Arai I; Hashimoto Y; Kurachi M
Eur J Pharmacol; 2004 Jul; 495(2-3):159-65. PubMed ID: 15249165
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2,4,6-trinitrochlorobenzene in NC mice.
Yamashita H; Makino T; Mizukami H; Nose M
Eur J Pharmacol; 2007 Jun; 563(1-3):233-9. PubMed ID: 17336291
[TBL] [Abstract][Full Text] [Related]
6. A new chronic itch model accompanied by skin lesions in hairless mice.
Ueda Y; Inoue T; Rahman MA; Yatsuzuka R; Jiang S; Kamei C
Int Immunopharmacol; 2006 Oct; 6(10):1609-15. PubMed ID: 16919833
[TBL] [Abstract][Full Text] [Related]
7. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization.
Hattori K; Nishikawa M; Watcharanurak K; Ikoma A; Kabashima K; Toyota H; Takahashi Y; Takahashi R; Watanabe Y; Takakura Y
J Immunol; 2010 Mar; 184(5):2729-35. PubMed ID: 20107184
[TBL] [Abstract][Full Text] [Related]
8. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
9. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
10. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
Kagawa Y; Izawa K; Yano H; Kamei C
Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
[TBL] [Abstract][Full Text] [Related]
11. Rutin suppresses atopic dermatitis and allergic contact dermatitis.
Choi JK; Kim SH
Exp Biol Med (Maywood); 2013 Apr; 238(4):410-7. PubMed ID: 23760007
[TBL] [Abstract][Full Text] [Related]
12. Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models.
Samukawa K; Izumi Y; Shiota M; Nakao T; Osada-Oka M; Miura K; Iwao H
J Pharmacol Sci; 2012; 118(3):391-400. PubMed ID: 22382656
[TBL] [Abstract][Full Text] [Related]
13. Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice.
Yatsuzuka R; Inoue T; Jiang S; Nakano Y; Kamei C
Eur J Pharmacol; 2007 Jun; 565(1-3):225-31. PubMed ID: 17459367
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
15. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
[TBL] [Abstract][Full Text] [Related]
16. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
[TBL] [Abstract][Full Text] [Related]
18. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
19. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
[TBL] [Abstract][Full Text] [Related]
20. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]